Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests:The funding organization(s) played no role in thestudy design; in the collection, analysis, and interpretationof data; in the writing of the report; or in the decision tosubmit the report for publication.
4. Ojito JW, Hannan RL, Burgos MM, Lim H, Huynh M, Velis E, et al. Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution. J Extra Corpor Technol 2012;44:15–20.Search in Google Scholar
5. Lewandrowski EL, Van Cott EM, Gregory K, Jang IK, Lewandrowski KB. Clinical evalution of the i-STAT Kaloin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center. Am J Clin Pathol 2011;135:741–8.10.1309/AJCPSF8ASGONNQM6Search in Google Scholar
6. Paniccia R, Fedi S, Carbonetto F, Noferi D, Conti P, Bandinelli B, et al. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. Anesthesiology 2003;99:54–9.10.1097/00000542-200307000-00012Search in Google Scholar
8. Schussler JM, Aguanno J, Glover E. Comparison of the i-STAT handheld activated clotting time with the Hemochron activated clotting time during and after percutaneous coronary intervention. Am J Cardiol 2003;464:466.10.1016/S0002-9149(02)03249-6Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston